Gene Query: GPS1

Dataset Description Geneva Score
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 48.76
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 41.39
Genome wide expression change by RNF168 knocking down in MCF-7 cells 28.2
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 23.64
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 23.61
Genome wide miR-191 target profile determined by RIP and gene expression profiling 23.61
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 21.95
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 21.95
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 21.39
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 20.4
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.15
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 19.82
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 18.31
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 18.29
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 17.97
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 17.97
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 17.4
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 17.01
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 16.9
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 16.69
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 16.65
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 16.55
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 16.36
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 16.36
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 16.28
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 15.98
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.77
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 15.29
Stem and effector CD8 T-cells from human cancers 14.87
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 14.78
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 14.18
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 14.18
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 14.02
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 14.02
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 13.59
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 13.59
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 13.56
Genome wide expression change by RNF168 knocking down in NEC cells 13.25
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.24
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 13.22
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 13.11
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 13.08
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 13.04
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 13.0
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 12.98
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 12.55
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.47
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 12.33
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.25
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 12.24
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 12.04
LncRNA expression profiling of ischemic stroke patients 12.04
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 12.01
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.95
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 11.77
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 11.75
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 11.71
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 11.71
MOF acetyl transferase regulates transcription and respiration in mitochondria 11.66
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.65
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.61
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 11.61
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 11.56
Studying the selectivity of a small molecule Synucleozid on transcriptome 11.56
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 11.52
Mechanistic Model-Guided Study of Embryonic Morphogenesis 11.41
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 11.4
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.36
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 11.33
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 11.33
U1 snRNP telescripting regulates size-function stratified human genome 11.22
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 11.2
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.2
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 11.15
Neurofibroma 11.15
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 10.99
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 10.94
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 10.93
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 10.93
Gene induction by the USP6 oncogene in response to interferon 10.78
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 10.77
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 10.61
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.6
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.53
Crizotinib v. DMSO in SW480 cells 10.41
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 10.38
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 10.32
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.32
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.32
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 10.31
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.13
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 10.12
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 10.12
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 10.04
Mitochondrial dsRNA triggers antiviral signalling in humans 9.98
Gene expression profiling of leukemia cells following asparagine depletion 9.93
FOXD3 is a novel tumor suppressor in lung cancer 9.93
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.74
An RNA-centric dissection of host complexes controlling flavivirus infection 9.74
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 9.74
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 9.73
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.71
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 9.59
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 9.57
Human Treg NaCl stimulation 9.5
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 9.45
Effect of Influenza virus infection on lncRNA expression in A549 cells 9.36
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 9.28
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.05
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 8.99
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.99
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.98
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.98
Survival of pancreatic cancer cells lacking KRAS function 8.94
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.74
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.71
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.68
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.38
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 8.38
Impact of dieldrin on transcription in Jurkat T cells 8.33
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.27
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.27
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 8.22
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 8.2
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 8.2
RNA sequencing of primary human platelets and in vitro cell lines 8.14
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.12
Genome wide expression change in LCC2 and MCF-7 cells 8.12
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 8.11
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.09
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.07
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.01
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.89
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 7.84
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.83
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.83
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 7.83
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.82
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.78
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 7.78
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 7.76
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 7.75
Differentially expressed genes post knock down of lincDUSP26 7.75
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.7
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 7.7
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.7
Capturing the Interactome of Newly Transcribed RNA 7.64
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.64
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.58
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 7.57
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.54
TT-Seq captures the human transient transcriptome 7.45
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.43
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.35
NRDE2 negatively regulates nuclear exosome functions 7.32
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 7.28
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 7.28
Hepatitis C virus functionally sequesters miR-122 7.27
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 7.27
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.26
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 7.21
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.2
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.16
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.16
Patient-derived luminal breast cancer xenografts with progestins 7.16
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 7.14
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 7.14
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.13
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 7.12
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 7.12
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 7.1
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 7.09
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.09
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 7.09
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 7.09
Landscape and variation of RNA secondary structure across the human transcriptome 7.06
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 7.04
High-throughput sequencing of pluripotent cells 7.02
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.93
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.93
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 6.91
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.9
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.88
RNA splicing alteration on glioblastoma and normal neural stem cells 6.87
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.86
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 6.84
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 6.8
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 6.77
T47D RNA-seq and ChrRNA-seq data 6.76
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.76
The effect of Abl kinases on non-small cell carcinoma global transcriptome 6.73
Lipid degradation promotes prostate cancer cell survival 6.71
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 6.69
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.67
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 6.67
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 6.65
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.64
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 6.64
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.56
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.56
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 6.55
Ectoderm specification of H1 human embryonic stem cells 6.55
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.55
Searching for target genes of miR-508/509/506/514 in HCT116 cells 6.54
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.53
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.51
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.49
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.44
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 6.42
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 6.42
METTL3 and WTAP 6.32
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.27
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.26
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.25
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 6.24
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 6.23
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 6.2
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 6.2
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 6.19
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 6.16
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 6.13
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.12
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.1
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 6.1
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 6.1
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.07
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.07
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 6.03
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.0
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 6.0
Evaluating pre-clinical models for studying NASH driven HCC. 5.98
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.95
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.95
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.91
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.86
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.86
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 5.76
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 5.75
Widespread regulated alternative splicing of single codons accelerates proteome evolution 5.75
Total RNA sequencing of WT intestinal orgaonids. 5.71
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.67
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.65
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.64
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 5.57
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 5.55
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 5.52
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.5
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 5.49
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 5.49
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.46
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 5.41
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.37
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.37
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.3
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.28
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.27
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.21
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.19
Identification of transcription start sites for human A549 cell line using ReCappable-seq 5.15
Illumina Total RNA-seq in HeLa 5.14
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 5.11
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 5.09
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.06
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.05
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.04
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.96
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.89
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.87
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.85
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.84
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.84
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.8
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.78
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.75
Transciptomic profiling of human fetal lung samples 4.7
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.66
Genome-wide functional assessment of enhancer activities in the human genome 4.64
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.6
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.6
Loss of CREBBP results in gene expression repression in lymphoma cells 4.6
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.58
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.53
RNAseq of cell lines with knocked in ESR1 mutations 4.48
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 4.46
DAOY-Notch1/Notch2 knockout: transcriptome comparison 4.36
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 4.35
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.34
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.26
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.26
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.19
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.17
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.06
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.06
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.0
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.97
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.88
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.79
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.78
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.77
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.75
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.75
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.73
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.71
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.71
SNHG5 siRNA knock down in HCT116 cells 3.65
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.61
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.61
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.59
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.59
Gene expression changes due to PARP knockdown in human cells 3.56
RNA editing in nascent RNA affects pre-mRNA splicing 3.55
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.49
Effect of PBK knockdown on C4-2 cell transcriptome 3.47
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.4
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 3.33
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.32
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 3.31
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.25
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.23
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.19
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.13
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.12
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 3.1
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.08
Global transcriptome analysis of WT versus HEB-/- hESCs 3.07
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.03
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.03
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 3.01
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.99
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.98
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.96
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.95
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 2.9
Patient-derived xenograft platform for metastatic melanoma 2.88
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.87
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.86
An optimization system for isolating and sequencing of single human colon cancer cells 2.86
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.85
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.78
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.77
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 2.75
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.7
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.67
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.65
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.65
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.65
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.6
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.6
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 2.6
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.59
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 2.59
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 2.59
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.58
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.58
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.57
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.56
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.55
SRSF1 role in cellular gene expression and splicing 2.45
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.43
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.43
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.43
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.41
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.38
Targeted enhancer activation by a subunit of the integrator complex 2.37
The DPYSL2 gene connects mTOR and schizophrenia 2.34
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 2.33
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 2.26
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 2.26
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.25
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 2.24
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.24
Interaction between mitoNEET and NAF-1 in cancer cells 2.18
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.14
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.14
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.13
miR-93 Targets in Human Endothelial Cells 2.12
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.12
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.07
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.06
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.98
Transcriptome analysis upon C6orf203 silencing 1.95
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.93
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.9
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.89
RNA-seq of SCLC PDX models treated with EP 1.85
RNA seq with AML (NB4) cells upon FTO inhibition 1.84
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.83
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 1.81
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 1.75
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.75
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.74
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.72
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.66
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.65
Iron response of HepG2 cells 1.65
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.65
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.65
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.64
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.64
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.62
HEK293 TFAM Knockout Expression Study 1.61
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.6
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.6
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.59
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.58
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.56
Gene expression profile in breast cancer cells 1.56
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.56
Polarized B -cell functions 1.53
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.5
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.49
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.47
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.46
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.46
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.44
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.39
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.39
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.39
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.35
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 1.29
Gene expression analysis upon mtDNA depletion 1.27
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.27
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.26
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.25
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.22
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.22
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.18
Tracking distinct RNA populations using efficient and reversible covalent chemistry 1.13
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.1
Comparative Analysis of Cas9 Activators Across Multiple Species 1.09
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.08
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.04
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.02
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.02
miRNAs affected by antagomiR-17 treatment 1.0
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.97
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.93
RNA-seq differential expression studies: more sequence, or more replication? 0.93
The bromodomain protein BRD4 regulates splicing during heat shock 0.9
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.9
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.89
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.88
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.87
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.87
Determining mRNA half-lives on a transcriptome-wide scale 0.79
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 0.78
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.77
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.76
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.75
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.72
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.69
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.64
RNA-seq of naive and primed ES cells (NHSM) 0.64
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.62
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.62
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.55
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.54
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.53
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.5
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.49
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.49
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.48
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.44
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.39
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.39
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.37
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.34
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.32
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.32
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.31
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.31
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.29
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.29
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.26
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 0.26
Regulatory network controlling tumor-promoting inflammation in human cancers 0.26
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.25
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.19
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.19
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.18
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.18
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.17
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.17
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.16
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.16
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.15
RNA-seq data from human lymphoma cell lines 0.12
ChIP-seq and RNA-seq from human lymphoma cell lines 0.12
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.11
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.1
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.09
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.06
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.06
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.06
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.05
The role of m6A/m-RNA methylation in stress response regulation 0.05
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.05
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation